Latest Market Share News

The ACCC has raised preliminary concerns that IAG’s proposed acquisition of RAC Insurance in Western Australia could reduce competition, potentially leading to higher premiums and limited repair service access for rivals.

Compumedics has secured FDA clearance for its single-use Somfit®D device, effectively doubling its addressable U.S. home sleep testing market to an estimated US$240 million annually. This milestone positions the company to capture significant market share with a dual-platform EEG-based solution.

Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.

Brambles Limited has clarified that its full-year 2025 earnings aligned closely with prior guidance and market expectations, with no material surprises. The company’s robust FY26 outlook, including increased dividends and a significant share buy-back, underpinned positive investor sentiment.

Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.

Sports Entertainment Group Limited has finalized its $3.25 million acquisition of RSN's brand and broadcasting assets, signaling a strategic move in Australia's media landscape.

Metal Powder Works has achieved a key validation milestone for its commercially pure titanium powder, confirming performance on par with industry benchmarks for cold spray applications. This breakthrough positions MPW to expand into the lucrative aerospace and advanced manufacturing markets.

ASF Group Limited reports a dramatic turnaround to a $25.8 million profit for FY2025, driven by a one-off $32.7 million gain from subsidiary disposals amid a 70% revenue drop.

Locality Planning Energy Holdings reports a 79% rise in group profit excluding impairment, signaling a pivotal transformation as it outlines ambitious FY2026 growth plans.

Cann Group Limited reported a 34% rise in dried flower production and doubled Botanitech brand flower sales in FY25, while cutting operating expenses by 35%. The company is targeting an EBITDA-positive FY26 amid ongoing debt restructuring.

Cann Group Limited reported a significant 56% reduction in net loss for FY25, driven by cost cuts and strong growth in dried flower sales, even as revenue declined due to shifting product preferences. The company faces going concern challenges but is actively pursuing debt refinancing and operational improvements.

Bioxyne Limited delivered a record FY25 with $30.4 million revenue, driven by Australian market growth and new European contracts. The company projects revenue up to $75 million in FY26, fueled by expanded production and international market entries.